Trials / Withdrawn
WithdrawnNCT03674450
Lung Heart Rate Variability
A Pilot Study at a Single Institution of Heart Rate Variability Biofeedback on Lung Cancer Patients Receiving Radiation Thearpy
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effects of heart-rate variability biofeedback training on lung cancer patients receiving definitive radiation therapy. The target population consists of non-small cell lung cancer (NSCLC) patients receiving 6 weeks of radiation therapy. The study will utilize the Physiolab GP8 heart rate variability and respiration system to collect data as well as several survey instruments to analyze quality of life measures. The goal is to show the HRV training can improve certain QOL measures like anxiety and sleep quality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Heart Rate Variability Biofeedback Training | The study will utilize the Physiolab GP8 heart rate variability and respiration system on a laptop computer used solely for the study with the proper security passwords to protect participant information. The equipment consists of two electrocardiogram sensors (one per wrist) attached by sports wrist bands, a respiration monitoring belt placed around the upper abdomen, two galvanic skin conductance sensors attached to the fingertips, and a thermistor sensor attached to one of the finger tips. Participants will perform a series of monitored breathing exercises. |
Timeline
- Start date
- 2019-01-02
- Primary completion
- 2019-04-11
- Completion
- 2019-04-11
- First posted
- 2018-09-17
- Last updated
- 2020-04-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03674450. Inclusion in this directory is not an endorsement.